1. Anlauf M, Sipos B, Kloppel G. [Tumors of the endocrine pancreas]. Pathologe 2005;26:46-51.
2. Gulec SA, Baum R. Radio-guided surgery in neuroendocrine tumors. J Surg Oncol 2007;96:309-315.
3. Kwekkeboom DJ, de Herder WW, Kam BL, van Eijck CH, van Essen M, Kooij PP, Feelders RA, van Aken MO, Krenning EP. Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival. J Clin Oncol 2008;26:2124-2130.
4. Muros MA, Varsavsky M, Iglesias Rozas P, Valdivia J, Delgado JR, Forrer F, Bodei L, Paganelli G. Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues. Clin Transl Oncol 2009;11:48-53.
5. O’Grady HL, Conlon KC. Pancreatic neuroendocrine tumours. Eur J Surg Oncol 2008;34:324-332.